US Pharma MarketingWhy direct-to-patient is the future of pharma access
Why direct-to-patient is the future of pharma access is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Gifthealth's CCO explains why DTP is no longer optional, - and how pharma teams can unlock its full potential.
Source: FiercePharma